Position in ALNY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$8,458,690
-$2,039,268 QoQ
Shares Held
25,565
-3.2% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026EFG International AG holds $77,956,469 across 38 Biotechnology names. ALNY ranks #1 (10.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
25,565 | $8,458,690 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
93,980 | $7,056,956 | |
| 3 | INSM |
INSMED Inc
|
40,542 | $6,629,425 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
83,729 | $6,217,714 | |
| 5 | SRRK |
Scholar Rock Holding Corp
|
112,730 | $5,541,806 | |
| 6 | PTGX |
Protagonist Therapeutics, Inc
|
50,086 | $5,279,063 | |
| 7 | KRYS |
Krystal Biotech, Inc.
|
20,049 | $5,179,057 | |
| 8 | ARGX |
Argenx SE
|
7,083 | $5,172,360 |
All Filings in ALNY
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,458,690 | 25,565 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $10,497,958 | 26,400 | Shares | Defined | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||